Search

Your search keyword '"Acyclovir administration & dosage"' showing total 5 results
Start Over Descriptor "Acyclovir administration & dosage" Region france
5 results on '"Acyclovir administration & dosage"'

1. [Bilateral dendritic keratitis].

Author

Duroi Q, Bonicel P, and Pisella PJ

Subjects
Acyclovir administration & dosage, Child, Female, France, Gels, Humans, Keratitis, Dendritic drug therapy, Photography, Keratitis, Dendritic diagnosis
Published
2018
Full Text
View/download PDF

2. A neonate with a challenging diagnosis (discussion and diagnosis).

Author

Mungan Akin I, Ozumut SS, Kocaturk E, Zemheri IE, Buyukkayhan D, and Ozdemir O

Subjects
Acyclovir administration & dosage, Aminoglycosides administration & dosage, Ampicillin administration & dosage, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Antiviral Agents administration & dosage, Antiviral Agents therapeutic use, Biopsy, Diagnosis, Differential, Drug Therapy, Combination, France, Histiocytosis, Langerhans-Cell congenital, Humans, Infant, Newborn, Skin Diseases, Vesiculobullous drug therapy, Acyclovir therapeutic use, Aminoglycosides therapeutic use, Ampicillin therapeutic use, Histiocytosis, Langerhans-Cell diagnosis, Skin Diseases, Vesiculobullous diagnosis
Published
2013
Full Text
View/download PDF

3. [Genital herpes: epidemiology, transmission, clinic, asymptomatic viral excretion, impact on other sexually transmitted diseases, prevention, and treatment].

Author

Bossi P

Subjects
2-Aminopurine administration & dosage, Acyclovir administration & dosage, Drug Therapy, Combination, Famciclovir, Female, France epidemiology, Guanine, Herpes Genitalis epidemiology, Herpes Genitalis prevention & control, Herpes Genitalis transmission, Herpesvirus 1, Human, Herpesvirus 2, Human, Humans, Male, Patient Education as Topic, Risk Factors, Valacyclovir, Valine administration & dosage, Virus Shedding, 2-Aminopurine analogs & derivatives, Acyclovir analogs & derivatives, Antiviral Agents therapeutic use, Herpes Genitalis drug therapy, Valine analogs & derivatives
Abstract

Genital herpes is one of the most widespread sexually transmitted diseases in the world. HSV2 predominates (60-80 p. 100), but the prevalence of HSV1 genital herpes is rising (20-40 p. 100). Erosive lesions of the genital organs due to HSV infection are a factor favoring HIV contamination and other sexually transmitted diseases. The main factor of transmission is asymptomatic viral excretion. Aciclovir, valaciclovir and famciclovir are effective treatment for genital herpes (primary infection, curative and preventive treatment of recurrence), but none of these compounds alters the natural history of the infection. Aciclovir given as a preventive measure reduces the load of asymptomatic viral excretion. Information and education of patients with genital herpes are key elements for prevention. Use of preservatives appears to be effective. New vaccine strategies favoring humoral and cellular response should be studied.

Published
2002

4. [Management of cutaneo-mucosal herpes in immunocompetent patients (ocular manifestations excluded)].

Subjects
Acyclovir administration & dosage, Acyclovir therapeutic use, Adult, Antibodies, Viral analysis, Antiviral Agents administration & dosage, Antiviral Agents therapeutic use, Child, Preschool, DNA, Viral analysis, Enzyme-Linked Immunosorbent Assay, Female, Fluorescent Antibody Technique, France, Herpes Genitalis diagnosis, Herpes Genitalis drug therapy, Herpes Genitalis therapy, Herpes Labialis diagnosis, Herpes Labialis drug therapy, Herpes Labialis therapy, Humans, Infant, Infant, Newborn, Male, Pemphigoid Gestationis diagnosis, Pemphigoid Gestationis drug therapy, Pemphigoid Gestationis therapy, Polymerase Chain Reaction, Pregnancy, Recurrence, Simplexvirus genetics, Simplexvirus immunology, Simplexvirus isolation & purification, Stomatitis, Herpetic diagnosis, Stomatitis, Herpetic drug therapy, Stomatitis, Herpetic therapy, Time Factors, Herpes Simplex diagnosis, Herpes Simplex drug therapy, Herpes Simplex prevention & control, Herpes Simplex therapy, Herpes Simplex transmission
Published
2002

5. Valaciclovir in herpes zoster ophthalmicus: new indication. An empty clinical assessment file.

Subjects
Acyclovir administration & dosage, Acyclovir adverse effects, Antimetabolites, Clinical Trials as Topic, France, Herpes Zoster Ophthalmicus complications, Humans, Treatment Outcome, Acyclovir therapeutic use, Herpes Zoster Ophthalmicus drug therapy
Abstract

(1) Valaciclovir, a metabolic precursor of aciclovir, improves the bioavailability of the active compound. It is licensed for the prevention of ocular complications of herpes zoster ophthalmicus in immunocompetent subjects. (2) The clinical file on valaciclovir in this indication is very thin. Only two (uninterpretable) trials have been done, both versus aciclovir. Note that oral aciclovir has also been assessed inadequately in this indication. (3) Over 10% of patients treated with valaciclovir in the two trials had nausea or headache.

Published
1999

Catalog

Books, media, physical & digital resources
See catalog results